Febuxostat Tablet
Product Images NDC 71610-450

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Febuxostat (NDC 71610-450). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 40 mg (71610 0450 60)

Bottle Label 40 mg (71610 0450 60)
Label for Febuxostat 40 mg oral tablets, a prescription drug. The label shows the NDC 71610-0450, recommended storage between 20-25°C, dispensing instructions to use a tight light-resistant container, and a warning to keep out of reach of children. It lists the manufacturer as Hikma Pharmaceuticals USA Inc. and the labeler as Aphena Pharma Solutions - Tennessee, LLC, located in Cookeville, TN.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Febuxostat Chemical Structure (Fcf23fa1 Bc2d 4cdf Bf25 51a9ee09fa0d 01)

Febuxostat Chemical Structure (Fcf23fa1 Bc2d 4cdf Bf25 51a9ee09fa0d 01)
Chemical structure of the active ingredient Febuxostat, showing its molecular connectivity and functional groups as depicted in the labeled diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.